Literature DB >> 33086084

The stress-immunity axis in shellfish.

Christopher J Coates1, Kenneth Söderhäll2.   

Abstract

It is a difficult task to describe what constitutes a 'healthy' shellfish (e.g., crustacean, bivalve). Visible defects such as discolouration, missing limbs or spines, fouling, lesions, and exoskeletal fractures can be indicative of underlying issues, senescence, or a 'stressed' animal. The absence of such symptoms is not evidence of a disease-free or a stress-free state. Now, more than ever, aquatic invertebrates must cope with acute and chronic environmental perturbations, such as, heatwaves and cold shocks, xenobiotic contaminants, intoxication events, and promiscuous pathogens expanding their host and geographic ranges. With that in mind, how does one determine the extent to which shellfish become stressed in situ (natural) or in cultured (artificial) settings to enhance disease susceptibility? Many biomarkers - predominantly biochemical and cellular measures of shellfish blood (haemolymph) - are considered to gauge immunosuppression and immunocompetence. Such measures range from immune cell (haemocyte) counts to enzymic activities and metabolite quantitation. Stressed invertebrates often reflect degraded conditions of their ecosystems, referred to as environmental indicators. We audit briefly the broad immune functions of shellfish, how they are modulated by known and emerging stressors, and discuss these concepts with respect to neuroendocrinology and immunotoxicology. We assert that chronic stress, alone or in combination with microbial, chemical and abiotic factors, increases the risk of infectious disease in shellfish, exacerbates idiopathic morbidity, and reduces the likelihood of recovery. Acute stress events can lead to immunomodulation, but these effects are largely transient. Enhancing our understanding of shellfish health and immunity is imperative for tackling losses at each stage of the aquatic food cycle and disease outbreaks in the wild.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease connectivity; Haemolymph biomarkers; Immunocompetence; Immunosuppression; Innate immunity; Microplastics; Neuroendocrinology

Mesh:

Year:  2020        PMID: 33086084     DOI: 10.1016/j.jip.2020.107492

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  6 in total

1.  Time-Course of the Innate Immune Response of the Terrestrial Crustacean Porcellio scaber After Injection of a Single Dose of Lipopolysaccharide.

Authors:  Andraž Dolar; Anita Jemec Kokalj; Damjana Drobne
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

2.  Hematodinium sp. infection does not drive collateral disease contraction in a crustacean host.

Authors:  Charlotte E Davies; Jessica E Thomas; Sophie H Malkin; Frederico M Batista; Andrew F Rowley; Christopher J Coates
Journal:  Elife       Date:  2022-02-18       Impact factor: 8.140

3.  The effects of electrical stunning on the nervous activity and physiological stress response of a commercially important decapod crustacean, the brown crab Cancer pagurus L.

Authors:  Douglas M Neil; Amaya Albalat; John Thompson
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

Review 4.  Impacts of microplastics on immunity.

Authors:  Wenjie Yang; Nahar Jannatun; Yanqiao Zeng; Tinghao Liu; Guofang Zhang; Chunying Chen; Yang Li
Journal:  Front Toxicol       Date:  2022-09-27

5.  Extrinsic and intrinsic drivers of parasite prevalence and parasite species richness in a marine bivalve.

Authors:  Kate E Mahony; Sharon A Lynch; Xavier de Montaudouin; Sarah C Culloty
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

6.  The diarrhetic shellfish-poisoning toxin, okadaic acid, provokes gastropathy, dysbiosis and susceptibility to bacterial infection in a non-rodent bioassay, Galleria mellonella.

Authors:  Helena Emery; William Traves; Andrew F Rowley; Christopher J Coates
Journal:  Arch Toxicol       Date:  2021-08-10       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.